GE HealthCare Technologies Inc. (GEHC) stock
GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 15/3011% below fair value
$83.66+1.82 (+2.22%)
Close on Nov 18, 2026Market cap $37.83BP/E 17.6Yield 0.17%
GE HealthCare Technologies operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
GE HealthCare Technologies's operating income for the twelve months ending Sep 30, 2026 was $2.89B, up 5.4% year over year. For fiscal 2025 it was $2.76B, up 5.3% from the year before. The highest annual figure on record is $2.80B in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.76B | +5.3% |
| FY2024 | Dec 31, 2024 | $2.63B | +7.8% |
| FY2023 | Dec 31, 2023 | $2.44B | -3.4% |
| FY2022 | Dec 31, 2022 | $2.52B | -9.8% |
| FY2021 | Dec 31, 2021 | $2.80B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $805.00M | +23.3% |
| Q2 FY2026 | Jun 30, 2026 | $739.00M | +13.0% |
| Q1 FY2026 | Mar 31, 2026 | $515.00M | -18.1% |
| Q4 FY2025 | Dec 31, 2025 | $827.00M | +3.2% |
| Q3 FY2025 | Sep 30, 2025 | $653.00M | -3.4% |
| Q2 FY2025 | Jun 30, 2025 | $654.00M | +7.6% |
| Q1 FY2025 | Mar 31, 2025 | $629.00M | +16.5% |
| Q4 FY2024 | Dec 31, 2024 | $801.00M | +16.3% |
| Q3 FY2024 | Sep 30, 2024 | $676.00M | +9.6% |
| Q2 FY2024 | Jun 30, 2024 | $608.00M | +6.7% |
| Q1 FY2024 | Mar 31, 2024 | $540.00M | -3.4% |
| Q4 FY2023 | Dec 31, 2023 | $689.00M | -11.3% |
| Q3 FY2023 | Sep 30, 2023 | $617.00M | +2.0% |
| Q2 FY2023 | Jun 30, 2023 | $570.00M | -9.7% |
| Q1 FY2023 | Mar 31, 2023 | $559.00M | +9.8% |
| Q4 FY2022 | Dec 31, 2022 | $777.00M | – |
| Q3 FY2022 | Sep 30, 2022 | $605.00M | – |
| Q2 FY2022 | Jun 30, 2022 | $631.00M | – |
| Q1 FY2022 | Mar 31, 2022 | $509.00M | – |
See a number that looks wrong?